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Despite rectal cancer is unusual before 40, fertility preservation (FP) remains a major concern for these
age-reproductive women. Treatment usually involves pelvic radiotherapy, neoadjuvant chemotherapy,
and surgery of rectum and mesorectum resection, at high risk of impairing fertility in women with risks of
premature ovarian failure and radio-induced uterus damage. To date, there is no consensus on FP strategy
for rectal cancer. We shared experiences between oncofertility experts from a French research network
GRECOT about a case of rectal cancer in a youngwoman. Indications, advantages and disadvantages of dif-
ferent FP strategies were discussed: ovarian transposition, cryopreservation of ovarian cortex and oocyte
vitrification. This case was the starting point that led to develop a French multidisciplinary e-meeting for
sharing experiences and for suggesting the best strategy when faced with a complex oncofertility case.
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Rectal cancer is a relatively rare disease, with an incidence of less than 1% in USA. In France, about 220 women
under 40 are concerned per year. However, US epidemiological data have shown an increase of rectal cancer
cases in women under 40 [1]. Management of rectal cancer most often combines neoadjuvant chemoradiotherapy
and surgical treatment including total proctectomy with total mesorectum excision [2]. Usually, pelvic radiotherapy
delivers doses of at least 45Gy,which are strongly reprotoxic for both the ovarian reserve and the uterus [3]. In addition
to the risk of dose-dependent premature ovarian failure (POF), radiotherapy induce inflammation and myometrial
fibrosis [4]. Fertility preservation (FP) before cancer treatment has been the subject of international guidelines and
must be integrated into the personalized care pathway of all children and age-reproductive women [5]. However,
there is no consensus on FP strategies for rectal adenocarcinoma. The possible FP techniques are transposing ovaries
out of the irradiation field, oocyte vitrification and ovarian tissue cryopreservation. However, these techniques do
not prevent the consequences of uterine irradiation. Based on a clinical observation, we reported the ‘no consensus
status’ of the FP strategy to offer to age-reproductive women with rectal cancer before starting treatment. In France,
a case study of rectal cancer in a young age-reproductive woman was discussed between oncofertility experts from
a research network GRECOT, that pointed out the difficulties to choose the best FP strategy for this pathology.
The objective of our article was to discuss specific FP strategies for rectal cancer and showed how a clinical case
could induce a new health-network think thank with the set-up of a national e-meeting dedicated to oncofertility
complex cases.
Special report
Our oncofertility team was faced with the case of a 26-year-old woman, treated for Crohn’s disease and diagnosed
with a lower rectum adenocarcinoma. The tumor was classified T3 N0 M0 by pelvic MRI and pelvic-abdominal-
thoracic CT. Oncologists recommended for this lower rectum tumor a combined chemoradiotherapy with a total
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Table 1. GRECOT expert advices about strategies to preserve fertility in a 26-year-old woman with rectal cancer.
Expert n◦1 COS for oocyte vitrification followed by ovariectomy 15 days later for OCP
No SOT
Expert n◦2 COS for oocyte vitrification followed by ovariectomy 15 days later for OCP
No SOT
Expert n◦3 SOT and OCP
Expert n◦4 COS for oocyte vitrification followed by ovariectomy 15 days later for OCP
No SOT
Uterine transposition
Expert n◦5 Difficuly to perfom SOT with stimulated and punctured ovaries
Bilateral SOT
In second line, after anticancerous treatment: COS for oocyte vitrification
Uterus: prone position during radiotherapy
Expert n◦6 Uterine transposition
Expert n◦7 Bilateral SOT (Despite SOT, left ovary is less protected against ionizing radiation)
Advise to associate partial left ovariectomy for OCP during the same surgical time.
Expert n◦8 Bilateral partial ovariectomy (1/3) for OCP and bilateral SOT during the same surgical time
Expert n◦9 Left ovariectomy for OCP and right SOT
COS: Controlled ovarian stimulation (followed by oocyte retrieval and cryopreservation); OCP: Ovarian cortex cryopreservation; SOT: Surgical ovarian transposition.
dose of 50.4 Gy and capecitabin at dose of 800 mg/m2 twice daily before surgery. The patient was referred to
the ONCOPACA-Corse Cancer and Fertility network to discuss options of FP before treatment. Ovarian reserve
assessment showed a antral follicle count with 15 follicles per ovary and anti-Mu¨llerian hormone (AMH) serum
level before treatment was 1.96 ng/ml. Because of different opinions in our unit between physicians concerning
‘best’ technique to be proposed, and at the patient’s request, a national multidisciplinary consultation was sent by
mail to expert members of the GRECOT (Groupe de Recherche en Cryoconservation Ovarienne et Testiculaire)
after anonymization of the identifying data. Results of this multiexpert consultation is reported in Table 1. Because
of foreseeable technical difficulties to perform ovarian surgery on stimulated and punctured ovaries, all opinions
rejected ovarian transposition after an oocyte vitrification cycle. Indeed, after stimulation, size of the ovaries is hugely
increased and theirmobilization from the pelvis could be technically difficult with an increased surgical risk. Suturing
distended and punctionned-stimulated ovaries to the anterior abdominal wall is also more difficult. Because of
ovarian stimulation and oocyte retrieval consequences on the macroscopic quality of ovarian cortex, embryologists
were opposed to perform ovarian cortex cryopreservation (OCP) immediately after ovarian stimulation. After
having exposed the different FP strategies with their own advantages and benefits, our patient chose to undergo
only a bilateral ovarian transposition. On the other hand, prone position for radiotherapy was recommended by
an expert to limit the dose received by the uterus. Before starting any anticancerous treatment, we performed a
bilateral ovarian transposition by laparoscopy. Thereafter, an intensity-modulated radiation therapy of 45 Gy was
administered in 25 fractions of 1.8 Gy on the mesorectum with a boost of 5.4 Gy in three fractions of 1.8 Gy
on the tumor. The mean dose of irradiation received by the uterus was 25.8 Gy. Mean dose received by ovaries
was 1.27 Gy. About 6 weeks after the end of radiochemotherapy, a total coloproctectomy with abdominoperineal
amputation and definitive ileostomy was performed. Final histopathological analysis diagnosed a 3 cm ypT2
N0-R0 adenocarcinoma. About 3 months later, a chest CT showed two pulmonary micronodules treated with
excision and radiofrequency that corresponded to metastases of rectal adenocarcinoma. Adjuvant chemotherapy
with 5-Fluorouracil - folinic acid and oxaliplatin were then administered every 15 days for 6 months.
After 2 years of remission, the patient expressed a desire for pregnancy that was allowed by the oncology team.
She had regular cycles, with normal menses. The thickness of the peri-implantation endometrium was measured
at 8 mm. As the ovaries were transposed, a reliable antral follicle count could not be performed. The AMH level
remained stable at 2.4 ng/ml. At the beginning of a cycle, follicle stimulating hormone was at 6.0 UI/l and E2
was 32.6 pg/ml. A pelvic MRI was performed in post-treatment to look for postradial uterus damage, and was
compared with the MRI performed in pretreatment. No significant changes were observed in uterus measurements,
endometrial or myometrial thickness or appearance of the endometrial-myometrial junctional zone (uterus length :
9 cm, antero-posterior diameter: 4 cm; transversal diameter: 5.3 cm). The patient and her partner wished to try to
achieve a spontaneous pregnancy and did not want to be actively managed with assisted reproduction techniques.
About 4 months later, she had a miscarriage at 7 weeks of gestation after a spontaneous pregnancy.
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The patient provided consent to share her medical file and to publish this report.
Discussion
For patients under 40, the incidence rate of rectal cancer has increased in the past decades but is still low at 0.5–2
cases/100,000 per year [1]. Recent data of the InCA (Institute National du Cancer – French National Institute for
Cancer) found that rectal cancer before 40 concerns about 220 age reproductive French women per year. Although
we have not precise data about the number of women who benefit of a FP for rectal cancer, experience reported by
experts was less than five cases per center (unpublished data). Rectal cancer treatments can impair fertility and this
case illustrates the difficulty to offer the optimal technique of FP for rare cancers in age-reproductive women. In
rectal cancer, radiotherapy is the main threatening treatment for woman’s fertility. An estimated threshold dose of
15 Gy induce ovarian dysfunction between 20 and 30 years [6]. Chemotherapy as capecitabine is not a gonadotoxic
chemotherapy and did not add ovarian damage [7,8]. Colorectal surgery provides postoperative pelvic adhesions.
In a meta-analysis, Broek et al. observed a significantly lower pregnancy rate after colorectal surgery in patients
with inflammatory bowel disease than patients with medical treatments only [9]. At our knowledge, the larger
retrospective cohort of FP for rectal cancer has been published by Elizur et al. with only six women with rectal
cancer [10]. At present, all FP techniques are quite recent with no hindsight on future fertility for these women.
Surgical ovarian transposition
Surgical ovarian transposition (SOT) was described in 1958 by McCall et al., and is the oldest FP technique
reported [11]. The objective of SOT is to decrease irradiation dose to ovaries by moving them from the pelvic area.
Several surgical techniques have been described [12]. The ovary with its pedicle is separated from the uterus and the
fallopian tube by sectioning ligaments. The blood supply to the ovaries is provided by the ovarian vessels in the
infundibulopelvic ligaments. Dissection of the infundibulopelvic ligaments peritoneum allows mobilization of the
ovary which is transposed to the anterolateral abdominal wall, and then sutured to the peritoneum, keeping them
outside of the irradiation field. On the inferior border of each ovary, surgical clips are placed to help radiotherapy
planning and evaluate received dose. After pelvic irradiation, ovarian transposition preserves endocrine ovarian
function in 60–80% of cases [6]. In a prospective study of 107 women with uterine cervical cancer, Morice et al.
reported a preserved endocrine function in 90% of cases [13]. Spontaneous pregnancy is possible even without
retransposition of the ovaries in the pelvis. In 11 women treated by chemotherapy and pelvic radiotherapy
for Hodgkin’s lymphoma in childhood and who underwent SOT, Terrenziani et al. reported 14 spontaneous
pregnancies with 12 live-births without ovarian retransposition [14]. In a retrospective cohort of six rectal cancer
cases, Elizur et al. performed a SOT with OCP for five patients and oocyte vitrification for one. One patient with
SOT and OCP obtained a spontaneous pregnancy and live birth, 2 years after the end of oncologic treatments [10].
To our knowledge, there are no other series reporting FP in case of rectal cancer.
Complications of SOT can occur in rare cases, but some are probably under-reported: only two cases of adnexal
torsion have been reported [15]. In cancer which is likely to extend to ovarian tissue, special attentionmust be required
to avoid transposition of ovaries with risk of metastasis. Ovarian metastasis are rare and concern less than 1% of
patients with rectal cancer [16]. The risk of ovarian metastasis cannot be totally eliminated but is very low in a
localized rectal cancer with macroscopic normal ovaries. A systematic review and meta-analysis of 828 patients
with gynecological cancers reported no metastatic ovarian malignancy following SOT [17]. The most frequent
complication was the development of benign ovarian cysts which occured in about 15% of cases. In 2018, ASCO
guidelines confirmed that SOT could be used as FP technique for women treated with pelvic radiotherapy [5]. Selter
et al. reported that in 828 young women treated by radiotherapy for pelvic malignancy in the USA between 2009
and 2014, less than 7% of them undergone a SOT [18]. Our case shows that SOT allowed to preserve endocrine
ovarian function and ovarian reserve despite high dose pelvic radiotherapy.
Ovarian cortex cryopreservation
OCP consists in performing a total or partial ovariectomy to cryopreserve nongrowing follicles of the ovarian
reserve into ovarian cortex. This technique aims to reimplant ovarian tissue after remission to restore both en-
docrine and exocrine ovarian function. OCP is indicated principally in high risk of POF treatments. The delay to
program laparoscopy for OCP is relatively short, and it can also be performed in women who require immediate
chemotherapy. After reimplantation of ovarian tissue, the endocrine function is restored in 95% of cases [19]. Meirow
et al. have reported the autograft of cryopreserved ovarian tissue from 20 women of which 15 received high-doses
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gonadotoxic chemotherapies before stem cell transplantation [20]. Among them, 19 women presented amenorrhea
with menopausal hormonal serums levels after stem cell transplantation. After autograft, 17 women recovered
regular periods with a FSH serum level <16 UI/l. Since the first live-birth after ovarian autograft in 2004, more
than 130 live-births have been reported worldwide [19,21]. Live-birth rate after ovarian autograft is among 30% [22].
However, these results mainly concern hematological malignancies, and few patients have undergone reimplanta-
tion of cryopreserved ovarian tissue after pelvic radiotherapy. The study of Diaz-Gracia et al. compared outcome
in 49 women who reutilized their vitrified oocytes versus 44 women who cryopreserved ovarian tissue followed
by an autograft [22]. The live-birth rate was not significantly different between the two groups but after ovarian
autograft, 46.7% of pregnancies occurred spontaneously. After ovarian autograft, all women except three resumed
or improved endocrine ovarian function. Rodriguez-Wallberg et al. reported a case of a in vitro fertilization live-birth
after ovarian autograft in a woman wich undergone a 54 Gy pelvic radiotherapy for Ewing’s sarcoma [23]. Contrary
to oocyte vitrification, reimplantation of cryopreserved ovarian tissue allows obtaining spontaneous pregnancies
and endocrine ovarian function recover. A histologic analysis of ovarian medulla and of a cortex biopsy for seeking
metastasis is always performed before OCP. Safety of OCP was evaluated by Hoekman et al. who evaluated the
ovarian tissue from 47 cancer women who have banked ovarian tissue for FP [24]. Among them, one woman had
rectal cancer. Only one woman with an intra-abdominal metastatic esophageal carcinoma had isolated tumoral cells
on her cryopreserved ovarian tissue. The risk of ovarian metastasis can’t be totally eliminated but is very small in
less than 1% of women with rectal cancer [16]. To date, the rate of reutilization of cryopreserved tissue after cancer
remission is low, between 3 and 5% [22,25], and to this day, this technique still needs evaluation, in particular
concerning the risk of relapse if residual disease is present in cortex.
Oocyte vitrification
In the last ASCO guidelines, oocyte vitrification was described as the ‘preferred’ FP technique [5]. After a controlled
multifollicular ovarian stimulation by gonadotrophins, oocyte retrieval is performed in aim to collect a maximum
of mature oocytes [26]. Vitrification is a particular technique of ultra-fast freezing in liquid nitrogen at -196◦C,
permitting cryopreservation of mature oocytes without intracellular crystallization. After thawing, oocytes could be
used for in vitro fertilization to get embryos. Ovarian stimulation is possible on a cycle day-independent schedule
but still requires in about 12 days to achieve stimulation and oocyte retrieval. There is no data available about the
outcome after oocyte vitrification for rectal cancer. Oocyte vitrification major drawback for FP is to leave the ovaries
exposed to pelvic radiotherapy with a risk of final POF. Moreover, this technique requires delaying treatment, and
often allows achieving a single or two cycles of ovarian stimulation with a limited number of harvested mature
oocytes. Oocyte cryopreservation alone does not seem sufficient to preserve fertility and ovarian function in rectal
cancer. Each oocyte give among 6% of chance to obtain a live-birth [27]. In case of POF induced by radiotherapy,
the vitrified oocytes will give only the chance to achieve a pregnancy and if the frozen-thawed oocytes are not
fertilized and/or if the obtained embryos do not implant, the woman will not have no more chance of pregnancy
and no possibility to restore endocrine function by ovarian autograft. If the woman does not recover endocrine
ovarian function because her ovaries haven’t be transposed or cryopreserved, hormone replacement therapy will also
be required.
Strategy in rectal cancer
In in our opinion, rectal cancer in age-reproductive women requires a specific management. A cohort study would
be interesting to assay the number of age-reproductive women referred to oncofertility center for rectum cancer.
In our practice, the referred women rate with rectal cancer seems low, about one or two per year and the larger
retrospective cohort reported only six women with rectal cancer [6].
Formost cancers, oocyte cryopreservation is to date described as the preferred option for FP inASCO’sGuidelines.
For a long time, ovarian cryopreservation was considered as an experimental technique, and recommandations have
to follow ‘emerging data that may prompt reconsideration of this designation in the future’. Recent studies
have reported similar live-birth rates after ovarian autograft versus embryo transfer after in vitro fertilization with
frozen-thawed oocytes [22].
All the FP techniques (SOT, OCP and oocyte cryopreservation) could be associated together, but technical and
time constraints can limit their combination in routine. Indications, benefits and drawbacks of each technique for
rectal cancer FP are summarized in Table 2. SOT and OCP aim to protect ovarian tissue from ionizing radiations.
For GRECOT’s experts, and in our own experience, SOT is technically difficult to perform with ovaries enlarged
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Table 2. Benefits, drawbacks and available data for different fertility preservation techniques in
young-age-reproductive with rectal cancer.
Technique Benefits Inconvenients Outcome data
Ovarian cortex
cryopreservation (OCP)
Short delay before starting anticancerous
treatment
Left ovary is less protected from ionizing
radiations, even after SOT, justifying left
ovariectomy for OCP
Full protection of cryopreserved cortex
from irradiation
OCP could be associated with SOT during
the same surgical time
Ovarian autograft permits to restore
endocrine function, sometimes during few
yearsPossibility of spontaneous pregnancy
after ovarian tissue autograft
Requires an additional laparoscopy before
treatment
Requires a second additional laparoscopy
after remission for ovarian autograftThe
quality of the neovascularization of
autografted cortex slices in irradiated
pelvis needs to be evaluated
More than 130 live births reported after
transplantation of cryopreserved ovarian
cortex
A case of live birth after pelvic irradiation
and transplantation of cryopreserved
ovarian tissue [22]90% preservation of
ovarian endocrine function
30% live birth rate after ovarian
transplantation
Ovarian surgical
transposition (SOT)
Short delay before starting anticancerous
treatmentPreserve ovarian endocrine
function
Requires of a supplementary laparoscopy
before starting
anticancerous treatmentOvaries, in
particular the left, are not totally protected
from irradiation
Abdominal pains, functional cysts on
transposed ovaries (15%)
More than 80% preservation of ovarian
endocrine function
Spontaneous pregnancies are possible
despite transposed ovaries
Oocyte vitrification No additional laparoscopy« preferred »
technique of FP in numerous disease
Requires a delay for ovarian stimulation (∼
12 days) before starting anticancerous
treatment
No preservation of endocrine function
Difficulty to associate with other FP
techniques
In vitro fertilization required to achieve
pregnancy
In case of irreversible effects of oncologic
treatments, no other chance of pregnancy
after having used all the vitrified oocyte
stock
 30% live birth rate after oocyte thawing
and IVF in cancer patients
No data in rectal cancer, and concerning
implantation rate of embryos in an
irradiated uterus
FP: Fertility preservation; OCP: Ovarian cortex cryopreservation; SOT: Ovarian surgical transposition.
by ovarian stimulation and oocyte pick-up. Likewise, embryologists reported the difficulties to cut thin slices of
ovarian cortex for OCP in a hyperstimulated and hemorrhagic ovary.
In our opinion, although there is no sufficient data on the best FP strategy in rectal cancer, and despite ASCO’s
guidelines [5], oocyte vitrification alone does not seem to be the most appropriate FP technique because ovarian
endocrine function is not protected against ionizing radiations with no chance to restore it after remission. Thus,
possible strategies of FP in case of rectal cancer that could be discussed are:
• Bilateral SOT. In a second time, a controlled ovarian stimulation for transcutaneous abdominal ovarian pick-up
could be discussed for cryopreserve oocytes. However, in this strategy, oocyte retrieval is technically most difficult.
• Combination of left ovarian OCP and right ovarian SOT
• unilateral ovariectomy (or ovarian bilateral cortex biopsies) for OCP followed by controlled ovarian stimulation
for oocyte vitrification [28]
• Ovarian bilateral cortex biopsies for OCP followed in the same surgical time by a bilateral SOT
We aimed to describe different FP techniques that could be proposed. As shown in Table 1, none of the experts
gave the same opinion. Finally, we proposed strategies that could be efficient and safe, but that require for each of
them further evaluation. More data with a large cohort study are required to evaluate the best strategy for preserving
endocrine function and long-term fertility in the specific case of rectal cancer in age-reproductive women. In our
case, the patient recovered spontaneous menses with a stable AMH level and had spontaneous pregnancy in few
months, confirming efficiency of SOT to preserve ovarian function and fertility. Moreover, this case was the starting
point of a national ‘brainstorming’ between oncofertility French experts that underlined the lack of consensus and
the impossibility to recommend a technique instead another for rectal cancer.
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Preservation of uterine function
Uterus damage due to pelvic radiotherapy should also be considered. The endometrium is a fast renewal tissue,
more sensitive to radiation whereas smooth muscle cells of myometrium are a slow renewal tissue with delayed
radiation effects. Histological study of irradiated uterus showed atrophic myometrium, with fibrosis and oedema at
the serosal surface. The irradiated endometrium is atrophic, with thickened and smaller blood vessels [29]. Radiation
exposure may induce reduced uterine volume and decrease the elasticity of uterine muscle that may result in
obstetrical complications. Lack of ovarian preservation leads to POF with histological uterine changes because of
hormonal deficiency [4]. Two studies evaluated by MRI the effects of pelvic irradiation on the uterus. Milgrom
et al. evaluated the uterus by dynamic contrast-enhanced MRI in ten patients with rectal cancer before and after
radiotherapy [30]. On T2 MRI, the junctional zone was visible in nine patients before and only in one after RT
(p = 0.001). Median cervical length (2.3 vs 3.0 cm) and endometrial thickness (2.6 vs 5.9 mm) were reduced
after RT. Uterine volume, myometrial thickness, myometrial and cervical signal intensity were not significantly
different between pre- and post-RT examinations. For decreasing uterine irradiation, various techniques of uterine
transposition have been described in patients with rectal cancer, but they are still experimental and require further
evaluation [31]. Pelvic radiotherapy is associated with an increased risk of maternal and neonatal complications.
Haggar et al. studied maternal and neonatal outcomes in 232 women treated for colorectal cancer. Compared with
colon cancer, rectal cancer was independently associated with a significantly higher risk of overall maternal and
neonatal adverse outcomes (odds ratios: 3.73 and 2.73, respectively), as well as after radiotherapy (odds ratios:
4.24 and 2.81, respectively) [32]. Radiotherapy in prone position has been proposed by radiation oncologists to
decrease radiations to small bowel and bladder in rectal cancer [33]. In our case, because of a retroverted uterus,
the radiation oncologist counseled to perform radiotherapy in prone position to decrease uterine irradiation dose
without undertreating rectal cancer. To our knowledge, no data are available about the efficiency of prone position
radiotherapy to decrease uterine damage and preserve fertility in rectal cancer. In the case we reported, 2 years after
treatment, the abundance of the menses associated at a normal thickness of the peri-implantation endometrium
give us hope that prone position for radiotherapy could have protected her uterus. Moreover, post-treatment MRI
did not show anatomical macroscopic differences after radiotherapy. However, despite these reassuring data, this
woman has an early miscarriage.
Conclusion
Rectal cancer in young-age-reproductive women is a rare condition with a high risk of impaired fertility. However,
in France, the question of FP for rectal cancer concerns about 200 young women per year and should be considered.
Several strategies combining different FP techniques as SOT, OCP and/or oocyte vitrification can be discussed. In
rectal cancer, FP must have two main objectives: preserving uterus and ovarian endocrine function from ioninizing
radiations and preserving gametes for restoring fertility. Despite limited data, SOT associated or not with OCP are
both techniques that seem most suitable to preserve both fertility and endocrine function in rectal cancer. However,
cohort studies are required to evaluate the best strategy for preserving endocrine function and long-term fertility.
Our first instinct that was asking our colleagues from all the country for seeking ultra-specialized advices leads us
to set-up in 2016 – with the technical help of the French Regional Cancer network and thank to a health public
financial support – an national e-meeting cancer & fertility to share medical opinions and experiences in case of
rare cancers [34].
Future perspective
The FP has become a major issue in the cancer management of reproductive-age women. For a lot of cancers in
young women, there is a lack of data and consensus for deciding ‘best’ FP strategy. When facing with a rare and/or
complex case, oncofertility practitioners need to share experiences and advices with ‘ultra specialized’ colleagues
for helping them to decide the best FP strategy. We believe that the set-up of a ‘e-network’ composed by national
oncofertility experts, and why not in the future by international experts, could improve the oncofertility patient’s
care. Our first French national e-meeting for oncofertility complex situations is maybe the first step before a large
collaborative oncofertility care e-network (http://www.oncopaca.org/f r/page/e-meeting-interregional-cas-complex
es-cancer-et-f ertilite).
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Executive summary
Surgical ovarian transposition
• Surgical ovarian transposition (SOT) is a surgical technique of fertility preservation that aim to decrease
irradiation dose to ovaries by moving them from the pelvic area and that allow to preserve endocrine ovarian
function in 60–80% of cases.
• Spontaneous pregnancy is possible even without retransposition of the ovaries in the pelvis.
Ovarian cortex cryopreservation
• Ovarian cortex cryoconservation (OCP) aims to cryopreserve nongrowing follicles of the ovarian reserve into
ovarian cortex for grafting ovarian tissue after remission to restore both endocrine and exocrine ovarian function.
• OCP is indicated principally before high risk of premature ovarian failure treatments.
• More than 130 pregnancies have been reported after autograft of frozen-thawed ovarian cortex.
Oocyte vitrification
• Oocyte retrieval is performed after ovarian controlled stimulation in aim to collect a maximum of mature oocytes
before vitrification.
• This technique needs a delay for ovarian stimulation (∼12 days) before starting anticancerous treatment.
• Despite good live-birth rate after thawing and in vitro fertilization, oocyte vitrification does not preserve ovarian
endocrine function.
Strategies that could be discussed in rectal cancer
• Oocyte vitrification alone does not seem to be the most appropriate FP technique in rectal cancer.
• Bilateral surgical ovarian transposition (SOT). In a second time, a controlled ovarian stimulation for
transcutaneous abdominal ovarian pick-up could be discussed for cryopreserving oocytes. However, in this case,
oocyte retrieval is technically most difficult.
• Combination of left ovarian OCP and right ovarian SOT.
• Unilateral ovariectomy or ovarian bilateral biopsies for OCP first, followed by COS with transvaginal ovarian
pick-up for oocyte cryopreservation.
• Ovarian bilateral biopsies for OCP followed in the same surgical time by a bilateral SOT.
• Cohort studies are required to evaluate long-term outcome after FP for rectal cancer and to determine the best
strategy for preserving both endocrine function and long-term fertility in rectal cancer.
Preservation of uterine function
• High dose pelvic radiotherapy leads to endometrium and myometrium damage.
• Pelvic radiotherapy is associated with an increased risk of maternal and neonatal complications.
• Prone position for radiotherapy should be discussed for decreasing the total dose of irradiation received on the
uterus.
• Various surgical techniques of uterine transposition have been described in patients with rectal cancer but are
still experimental.
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